Cephalon Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 800

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.8B

Cephalon General Information

Description

Developer of pharmaceuticals intended to treat diseases related to central nervous system, oncology and inflammatory diseases. The company's research, development, manufacturing, and marketing activities focused on therapies for central nervous system disorders, cancer, pain and inflammatory disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 41 Moores Road
  • Frazer
  • Malvern, PA 19355
  • United States
Primary Industry
Pharmaceuticals
Corporate Office
  • 41 Moores Road
  • Frazer
  • Malvern, PA 19355
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cephalon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Oct-2011 $6.8B Completed Generating Revenue
3. Merger/Acquisition 05-Apr-2011 Cancelled Generating Revenue
2. IPO 25-Apr-1991 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Cephalon’s complete valuation and funding history, request access »

Cephalon Patents

Cephalon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2011146488-A1 Method for purifying a fused pyrrolocarbazole derivative Inactive 18-May-2010
JP-2013526573-A Method for purifying molten pyrrolocarbazole derivatives Active 18-May-2010
WO-2011086194-A1 Improved oral lysophilisates containing pvp/va Inactive 18-Jan-2010
EP-2359812-A1 Oral lyophilised compositions Inactive 18-Jan-2010
WO-2011086193-A1 Oral lyophilized compositions Inactive 18-Jan-2010 A61K9/0056
To view Cephalon’s complete patent history, request access »

Cephalon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cephalon Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
InterWest Partners Venture Capital Minority
New Leaf Venture Venture Capital Minority
New Science Ventures Venture Capital Minority
Oak Investment Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Cephalon Investments & Acquisitions (21)

Cephalon’s most recent deal was a Later Stage VC with JSK Therapeutics for . The deal was made on 11-Dec-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
JSK Therapeutics 11-Dec-2017 Later Stage VC Drug Discovery
Fachklinik Osterhofen 10-Jan-2012 Merger/Acquisition Clinics/Outpatient Services
Gemin X Pharmaceuticals 01-Apr-2011 Merger/Acquisition Drug Discovery
Chemgenex Pharmaceuticals 29-Mar-2011 Merger/Acquisition Biotechnology
Mesoblast 11-Feb-2011 PIPE Drug Discovery
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Cephalon Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Fachklinik Osterhofen Osterhofen, Germany 1999
Mepha Basel, Switzerland 1949

Cephalon FAQs

  • When was Cephalon founded?

    Cephalon was founded in 1987.

  • Where is Cephalon headquartered?

    Cephalon is headquartered in Malvern, PA.

  • What is the size of Cephalon?

    Cephalon has 800 total employees.

  • What industry is Cephalon in?

    Cephalon’s primary industry is Pharmaceuticals.

  • Is Cephalon a private or public company?

    Cephalon is a Private company.

  • What is the current valuation of Cephalon?

    The current valuation of Cephalon is .

  • What is Cephalon’s current revenue?

    The current revenue for Cephalon is .

  • Who are Cephalon’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania, InterWest Partners, New Leaf Venture, New Science Ventures, and Oak Investment Partners are 5 of 7 investors who have invested in Cephalon.

  • When was Cephalon acquired?

    Cephalon was acquired on 14-Oct-2011.

  • Who acquired Cephalon?

    Cephalon was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process